All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2018-004269-14 | Loss of RESponse to Ustekinumab treated by dose Escalation Verlies van respons op ustekinumab behandeld via dosis escalatie Perte de réponse à l’ustékinumab traitée par augmentation de la dose. | not-yet-due | |
Ongoing | 2021-000345-41 | An Open-Label Extension and long-term efficacy and safety monitoring study of patients with Crohn’s disease previously included in the loss of RESponse to Ustekinumab treated by dose Escalation study ... | not-yet-due |